GoKawiilReport urges faster use of whole genome sequencing to cut rare disease diagnosis delays
A commentary argues that healthcare systems should stop delaying whole genome sequencing for certain patients, saying rare disease diagnoses often take years to reach. It contends the cost of that delay should be counted not just in time but in dollars, clinical capacity, and missed chances for better treatment.